vimarsana.com

Greg Siller News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nevro Corp (NYSE:NVRO) Q4 2023 Earnings Call Transcript

Nevro Corp. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.5. Nevro Corp.

Costa ricaCanaccord genuityAdam maederKevin thornalJoanne wuenschAngie mccabeBrandon vazquezShagun singhPiper sandlerGreg sillerNathan treybeckKallum titchmarshRichard newitterLarry biegelsenWilliam blairAnthony petrone

Nevro stock is down on slashed 2023 guidance

Nevro stock lost more than a fifth of its value a day after the maker of spinal cord stimulation devices greatly reduced its 2023 guidance.

Costa ricaUnited statesRedwood cityKevin thornalMassdevice medtechSamuel brodovskyRichard newitterGreg sillerLin zhangChief commercial officer

Nevro Corp (NYSE:NVRO) Q2 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, good afternoon. My name is Abby, and I will be your conference operator today.

United statesCosta ricaErika petersenShagun singhDavid turkalyAllen gongDave turkalyRichard newitterGreg sillerWilliam plovanicSimran kaurBrandon vazquezBrad bowersGreg chodaczekKevin thornalAnthony petrone

Nevro names new chief commercial officer

Nevro this week announced it appointed Greg Siller as senior VP and chief commercial officer, effective June 19.

Kevin thornalGreg sillerNiamh pellegriniStryker interventional spinePresident kevin thornalInterventional spine

Nevro Names New Chief Commercial Officer

Organizational Change Designed to Drive Strong Growth and Advance Global Commercial Focus Company Updates Second Quarter 2023 Revenue Guidance REDWOOD CITY, Calif., June 5, 2023 /PRNewswire/ . | June 5, 2023

United statesRedwood cityGreg sillerNiamh pellegriniKevin thornalJulie deweyNevro corpCompany updates second quarterCorp communicationsUniversity of new hampshireExchange commissionPrnewswire nevro corpOrganizational change designedDrive strong growthAdvance global commercial focusUpdates second quarter

vimarsana © 2020. All Rights Reserved.